<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03854006</url>
  </required_header>
  <id_info>
    <org_study_id>22012019</org_study_id>
    <nct_id>NCT03854006</nct_id>
  </id_info>
  <brief_title>Cryoballoon Pulmonary Vein Isolation: Time-to-Isolation Dependent Freeze Protocols Comparison</brief_title>
  <official_title>Cryoballoon Pulmonary Vein Isolation: Time-to-Isolation Dependent Freeze Protocols Comparison</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Medical Universtity of Lodz</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Medical Universtity of Lodz</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to develop and prospectively test two Cryo-AF (atrial
      fibrillation) dosing protocols guided exclusively by time-to-isolation (TT-I) in patients
      undergoing a first-time Cryo-AF.

      Both protocols guided by TT-I are associated with shorter cryoapplications as compared to
      conventional approach.

      In the first group freeze duration is TTI +120 s. In the second group freeze duration is 240s
      if TTI is &lt; 75 s. In case of TTI&gt;75s a 240s bonus freeze is applied.

      The investigators examine long-term efficacy of Cryo-AF using the two proposed dosing
      algorithms in a nonrandomized fashion.

      The study cohort consists of consecutive patients undergoing a first-time Cryo-AF for
      symptomatic paroxysmal or persistent AF (atrial fibrillation) at Interventional Cadiology and
      Cardiac Arrhythmias Clinic of Medical University in Łódź. During 12 months investigators are
      planning to enroll 40 patients Patients are randomly assigned to the groups. All of them will
      be followed up 3 and 12 months after the procedure. In addition, ambulatory
      electrocardiographic monitoring will also be performed at 3 and 12 months.

      The study is requested for an approval of the university ethics committee.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">May 1, 2019</start_date>
  <completion_date type="Anticipated">May 2021</completion_date>
  <primary_completion_date type="Anticipated">May 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>The investigators will examine long-term efficacy of Cryo-AF using the two proposed dosing algorithms in a nonrandomized fashion.</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Atrial Fibrillation Recurrence</measure>
    <time_frame>3 months after the procedure</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Atrial Fibrillation Recurrence</measure>
    <time_frame>12 months after the procedure</time_frame>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">40</enrollment>
  <condition>Atrial Fibrillation</condition>
  <arm_group>
    <arm_group_label>Freeze cycle: 240 s - TTI &lt;75 s or 2x240 s - &gt;75 s</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>In the first group freeze duration is 240s if TTI (time-to-isolation) is &lt; 75 s. In case of TTI&gt;75s a 240s bonus freeze is applied.
If no TTI could be documented, a single 240 s freeze cycle is applied in this group in case of balloon temperature -40°C (degrees Celsius) after 60 s.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Freeze cycle: TTI+120 s</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>In the second group freeze duration is TTI (time-to-isolation) +120 s. If no TTI could be documented, a single 180 s freeze cycle is applied in this group in case of balloon temperature -40 °C after 60 s.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Cryoballoon pulmonary vein isolation</intervention_name>
    <description>During cryoballoon pulmonary vein isolation, under local anaesthesia, diagnostic catheters are placed in the coronary sinus. The cryoballoon is advanced to the left atrium via a steerable sheath after single transseptal puncture and inflated at the PV(pulmonary vein) ostia. A spiral mapping catheter is advanced through the balloon inner lumen and positioned in the PV at the closest achievable proximity to the cryoballoon in order to record real-time PV potentials during PV isolation. During PV isolation the potentials from the PV are recorded. The TTI is defined as the time of the last recording of a PV potential before sustained isolation. Isolation of all PVs is reassessed at the end of the procedure by documentation of entrance- and exit-block.</description>
    <arm_group_label>Freeze cycle: 240 s - TTI &lt;75 s or 2x240 s - &gt;75 s</arm_group_label>
    <arm_group_label>Freeze cycle: TTI+120 s</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

        Diagnosis of Paroxysmal or Persistent Atrial Fibrillation on Electrocardiogram

        Exclusion Criteria:

        Diagnosis of Sinus Rhythm on Electrocardiogram
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Andrzej Lubinski, MD, PhD</last_name>
    <role>Study Director</role>
    <affiliation>Medical University of Lodz</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Izabela Warchoł</last_name>
    <phone>794982391</phone>
    <phone_ext>+48</phone_ext>
    <email>izabelaritawarchol@gmail.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Tomasz Kucejko</last_name>
    <email>tomaszkucejko@gmail.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Uniwersytecki Szpital Kliniczny im. Wojskowej Akademii Medycznej - Centralny Szpital Weteranów</name>
      <address>
        <city>Łódź</city>
        <state>Łódzkie</state>
        <zip>90-549</zip>
        <country>Poland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Izabela Warchoł</last_name>
      <phone>794982391</phone>
      <phone_ext>+48</phone_ext>
      <email>izabelaritawarchol@gmail.com</email>
    </contact>
  </location>
  <location_countries>
    <country>Poland</country>
  </location_countries>
  <verification_date>November 2019</verification_date>
  <study_first_submitted>February 16, 2019</study_first_submitted>
  <study_first_submitted_qc>February 23, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">February 26, 2019</study_first_posted>
  <last_update_submitted>November 13, 2019</last_update_submitted>
  <last_update_submitted_qc>November 13, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">November 14, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Medical Universtity of Lodz</investigator_affiliation>
    <investigator_full_name>Izabela Warchol</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <keyword>Atrial Fibrillation</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Atrial Fibrillation</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

